Literature DB >> 20393857

"The choice for death" and neurology.

Anna Durnová1, Herbert Gottweis.   

Abstract

In the last decade, "end-of-life" issues have gained prominence in political and social debates in many countries. The deliberate ending of the life of a patient upon his/her own request has become a hotly contested topic. This paper discusses the implications of this debate and of corresponding policy and legal developments for neurology. We discuss the nomenclature of the "choices for death", euthanasia, doctor-assisted suicide and palliative care as well as the social dynamics underlying these developments. We suggest that we need a more nuanced and empirically based understanding of the process of the "choice for death and its implications for medical practice."

Entities:  

Mesh:

Year:  2010        PMID: 20393857     DOI: 10.1007/s00415-010-5554-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  4 in total

1.  Between hope and acceptance: the medicalisation of dying.

Authors:  David Clark
Journal:  BMJ       Date:  2002-04-13

2.  Rationing failure. The ethical lessons of the retransplantation of scarce vital organs.

Authors:  P A Ubel; R M Arnold; A L Caplan
Journal:  JAMA       Date:  1993-11-24       Impact factor: 56.272

3.  Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands.

Authors:  Jan H Veldink; John H J Wokke; Gerrit van der Wal; J M B Vianney de Jong; Leonard H van den Berg
Journal:  N Engl J Med       Date:  2002-05-23       Impact factor: 91.245

4.  Concept of unbearable suffering in context of ungranted requests for euthanasia: qualitative interviews with patients and physicians.

Authors:  H R W Pasman; M L Rurup; D L Willems; B D Onwuteaka-Philipsen
Journal:  BMJ       Date:  2009-11-16
  4 in total
  1 in total

1.  Attitudes towards end-of-life decisions and the subjective concepts of consciousness: an empirical analysis.

Authors:  Lorella Lotto; Andrea Manfrinati; Davide Rigoni; Rino Rumiati; Giuseppe Sartori; Niels Birbaumer
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.